P/E ratio for Qiagen (QGEN)
P/E ratio as of June 2023 (TTM): 30.2
According to Qiagen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.1691. At the end of 2021 the company had a P/E ratio of 24.7.
P/E ratio history for Qiagen from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 24.7 | -26.91% |
| 2020 | 33.8 | -118.28% |
| 2019 | -185 | -552.32% |
| 2018 | 40.9 | -76.89% |
| 2017 | 177 | 106.14% |
| 2016 | 85.8 | 70.09% |
| 2015 | 50.5 | 7.74% |
| 2014 | 46.8 | -41.6% |
| 2013 | 80.2 | 140.06% |
| 2012 | 33.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 33.7 | 11.66% | 🇺🇸 USA |
 Becton Dickinson BDX | 47.0 | 55.71% | 🇺🇸 USA |
 General Electric GE | -258 | -955.50% | 🇺🇸 USA |
 Hologic HOLX | 26.2 | -13.16% | 🇺🇸 USA |
 Bio-Techne TECH | 47.9 | 58.83% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.